The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
It’s the same excitement I would have got back in December :( maybe it just happens automatically after an RNS is posted or something!
IKN it happened in December as well, it means nothing.
Haha the same thing happened in December on this share
Do we really think that lse would know the share is back live before the rest of the market?
Why does it take 3 weeks to post that RNS, this is ridiculous.
British made... sounds like a far more expensive cost per item and greatly reduced margin!
And to clarify my comment, the big4 are providing comments to client companies as their advisors (not their auditors). This is generally allowed for the vast majority of companies, just not the sizeable ones (e.g. SEC, FTSE etc). So the audit is irrelevant, as this is advice, not preliminary audit work.
REPLY TO CHALKER ‘ The reference to 2 of the big 4 is of little relevance. The fact that a couple of audit partners have not yet twigged that the accounting is not appropriate means nothing. Any accountant will tell you that the main audit fieldwork is not done until the end of the accounting year - i.e up to another year away. Especially for smaller clients. It's actually surprising that the 30 or so clients involved in the first monetisation does not encompass all of the big 4. Perhaps due to the clients being pretty small?’
I’ve had my reservations about the accounting treatment (see my last post here), but it’s clearly stood up to scrutiny from 2 of the big 4, they don’t sign off with any certainty unless they are sure. Also, the comment about the audit being done at the end of the year is irrelevant, Crowe are the auditors, this is just an opinion from big 4. And the fact they agree with both SYME and each other is hugely positive. I might buy back in here to be honest, looking very positive.
Can be both, but for a listed company it won’t usually be a director, so yea he’d only be on there if he had >25% of the shares.
Isn’t RNS Reach just the full name of the news service? So when you get an RNS it’s coming from RNS Reach.
I don't get the issue here? The antiviral mask with 4ply has passed the test? So why do we care about the others? Just produce the 4 ply on, buy the dips.
Does this screw us though or is this what we were expecting? We knew they were being wound up so we expected them to be delisted, and there will then just be a distribution to shareholders if there are surplus funds once creditors have been paid. I guess CFDs won't get paid, but that's to be expected.
Amigo has been the most stressful share I’ve had over the past 6 months hahaha, got in at 5p initially before I even knew who JB was, the rollercoaster over the past few months with his proposal etc. made me slowly exit it completely... now decided to stress myself out here, RMS and ICON... not sure why I do it to myself
How is the company worth more than that? It’s an investment company with limited cash left and no significant investments. Value of the company will actually be well below 13p per share, it’s relying on smart investment decisions, but the main brains will be taking his huge dividend and leaving.